| Title: |
Durvalumab With Olaparib and Paclitaxel for High-Risk HER2-Negative Stage II/III Breast Cancer: Results From the Adaptively Randomized I-SPY2 Platform Trial |
| Authors: |
Pusztai, Lajos; Yau, Christina; Wolf, Denise M.; Han, Hyo S.; Du, Lili; Wallace, Anne M.; Stringer-Reasor, Erica; Boughey, Judy C.; Chien, A. Jo; Elias, Anthony D.; Beckwith, Heather; Nanda, Rita; Albain, Kathy S.; Clark, Amy S.; Kemmer, Kathleen; Kalinsky, Kevin M.; Isaacs, Claudine; Thomas, Alexandra; Shatsky, Rebecca; Helsten, Teresa L.; Forero-Torres, Andres; Liu, Minetta C.; Brown-Swigart, Lamorna; Petricoin, Emmanuel F.; Wulfkuhle, Julia D.; Asare, Smita M.; Wilson, Amy; Singhrao, Ruby; Sit, Laura; Hirst, Gillian L.; Berry, Scott; Sanil, Ashish; Asare, Adam L.; Matthews, Jeffrey B.; Perlmutter, Jane; Melisko, Michele; Rugo, Hope S.; Schwab, Richard B.; Symmans, W. Fraser; Yee, Doug; van't Veer, Laura; Hylton, Nola M.; DeMichele, Angela M.; Berry, Donald A.; Esserman, Laura J. |
| Source: |
SSRN Electronic Journal ; ISSN 1556-5068 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2020 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.2139/ssrn.3751802 |
| Availability: |
http://dx.doi.org/10.2139/ssrn.3751802 |
| Accession Number: |
edsbas.52D9AD8A |
| Database: |
BASE |